Get to market faster
with our Technology Vitality Report
A Technology Vitality Report is a means of quantitatively evaluating an invention description. It provides a proprietary Novelty Score that offers powerful insights for assessing an invention description for novelty and market, allowing inventors, engineers, managers, and professionals to make informed decisions on moving a disclosure forward. The TVR uses Semantic Gist, IP.com’s proprietary AI engine to power comprehensive IP evaluation, allowing you to rank ideas quickly, efficiently, and transparently. Our TVR accelerates the decision-making process by enabling fast, data-backed prioritization.
IP.com’s Patent Insight Indexes, business managers can obtain the information needed to effectively identify high and low-quality intellectual assets in both their own portfolio and in competitors portfolios. In addition, objective data enable managers to apply quality and value metrics to the intellectual property management process.
The AI-generated, automated Technology Vitality Report (TVR) allows you to rank ideas quickly, efficiently, and transparently. Quickly review hundreds of invention disclosures, funnel the lower quality ideas to send back to the inventor for further iteration, or fast-track novel ideas to the review committee. Our TVR accelerates the decision-making process by enabling fast prioritization.
With the latest enhancements to the TVR, a more detailed analysis, when needed, is just a click away. Whether you’re interested in more specificity around prior art to pass back to the inventor, exploring the competitive landscape, or the recent filing trends, the new interactive TVR dashboard can provide you with the information you want at a glance with the click of a button. Review and understand the closely related art, applying filters to give you the information necessary to make informed decisions on invention disclosures. Share limited or full results with inventors or teams, even those without a seat of InnovationQ+™, to help draft future invention disclosure iterations.
accelerating your innovation to Protect key inventions or technologies faster
Our IP evaluation incorporates predictive analytics and workflow solutions to help teams validate R&D ideas. Your business will be able to make better innovation decisions – faster.
Organizations processing many ideas intend to accelerate innovation to protect critical technologies and get to market faster. With potentially hundreds of ideas generated weekly, review and evaluation are timely and expensive.
SAVE TIME to get inventions & products to market quickly
When the goal is to increase internal efficiency, reduce outsourcing costs, and achieve favorable patent actions, our Technology Vitality Report is your IP evaluation solution. Our AI-driven technology expedites the process of invention disclosure review. Your organization can accelerate the vital task of determining whether to patent, publish, or keep the technology a trade secret.
No matter how quickly or in-depth you want to review disclosures, the AI-enabled TVR solution allows you to prioritize and manage your workflow, saving time and bringing ideas to market faster.
Providing Actionable data
Evaluate the strength of an individual idea or tech
The TVR uses machine learning and statistical analysis of prior art to evaluate an idea’s or individual technology’s strength. This AI-enabled solution delivers real-time novelty and market position scoring. It uses patent-pending IP evaluation methodology to help teams “rank” ideas with enhanced accuracy using a patented blend of semantic signatures and keyword models.
AI within the engine scores the novelty of a concept and generates an objective score related to your invention disclosure. This quick, objective feedback enables you and your review committee to prioritize the disclosure pipeline and make value-based decisions in real-time. The TVR is more than a report; this tool creates a process. When needed, perform a more in-depth analysis of your TVR results as a part of your prioritization workflow. Explore your results in InnovationQ+™ to review full prior art documents and non-patent literature with just a few clicks.
- Calculates an unbiased, objective score that facilitates quick decision making
- Streamlines a manual process by automating the assessment of ideas
- Scores each technology to help determine whether to patent, publish, or keep the technology a trade secret
- Serves as a bridge between R&D departments and IP teams
- Shortens the innovation cycle by giving engineers an objective analysis of the concept faster
- Enables stronger patent applications due to more insight into why the idea is imitative or novel
- Streamlines work of internal counsel and may reduce the need for incurring consultant fees using outside counsel
- Secures batch uploads of invention disclosures into an internal docketing system or allows results to be exported
Ready to get started?
Request a Technology Vitality Sample Report
Fill out the form and we will be in touch shortly with your download.
Technology News & Resources
Explore AI at IP Watchdog AI Masters 2024! Join the event for discussions on AI and ML. As proud sponsors, we’ll be showcasing innovations from March 4-6, 2024, in Ashburn, Virginia. Connect with us, preview exclusive features, and dive into the future of AI in intellectual property.
How the New USPTO Pre-Application Assessment Program Only Reinforces the Need for Integrated & Intelligent Patent Evaluation Software
With a steady increase in patent submission rate and added strain on the patent review and approval system, the USPTO has announced plans to launch a new pre-application review program called the “Pre-Prosecution Pilot” as part of its continuing commitment to expand access to the innovation ecosystem and support under resourced inventors.
In recent news, Apple has faced a patent infringement suit regarding the blood oxygen technology in two of its Apple Watch Series models resulting in a halt in sales of their watch models. The halt in sales comes after the International Trade Commission ruled that these two models’ use of blood oxygen tracking violated a patent from health technology company Masimo.